Therapeutics
Therapeutics
We are expanding the drug discovery space to tackle the hard to treat diseases
Therpautic Areas
Our technology is uniquely suited to the development of biomarkers, therapeutic targets and treatments for highly complex conditions in which cells exhibit inappropriate patterns of differentiation and protein expression, including many common diseases.
We are initially focused on developing a pipeline for autoimmune indications.
Pipeline
Programs
3D screening and genetic validation
3D screening and genetic validation
3D screening and genetic validation
Proof of concept
Proof of concept
Proof of concept
Dev. Candidate selection & IND enabling
Dev. Candidate selection & IND enabling
Dev. Candidate selection & IND enabling
IBD
EG-011
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-014
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-017
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-018
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
IBD
EG-011
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-014
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-017
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-018
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
IBD
EG-011
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-014
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-017
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-018
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
Alzheimer's Disease
EG-001
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-003
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-006
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-007
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
Alzheimer's Disease
EG-001
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-003
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-006
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-007
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
Alzheimer's Disease
EG-001
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-003
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-006
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
EG-007
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
Undisclosed Indication
EG-XXX
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
Undisclosed Indication
EG-XXX
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
Undisclosed Indication
EG-XXX
Target
Development Candidate
Lorem ipsum.
Modality
Lorem ipsum.
Background
Explore our platform technology or reach out to learn more
© 2026 Enhanced Genomics. All rights reserved.
© 2026 Enhanced Genomics. All rights reserved.
© 2026 Enhanced Genomics. All rights reserved.